NEW YORK — MBio Diagnostics said today that it has been awarded a roughly $1 million grant from the National Institutes of Health grant to develop a point-of-care assay for sepsis.
The company also said it has received a contract from the Henry M. Jackson Foundation for a separate sepsis test, but the size of the contract was not disclosed.